Literature DB >> 16153673

RSV-induced prostaglandin E2 production occurs via cPLA2 activation: role in viral replication.

Tianshuang Liu1, Wahiduz Zaman, Bhupendra S Kaphalia, G A Shakeel Ansari, Roberto P Garofalo, Antonella Casola.   

Abstract

Prostaglandins (PGs) are lipid mediators that participate in the regulation of immunological and inflammatory responses, and PG production can affect viral replication. In this study, we have investigated the mechanism of PGE2 production in airway epithelial cells, following respiratory syncytial virus (RSV) infection, and its role in viral replication. We show that RSV infection strongly induces PGE2 secretion, in a time- and replication-dependent manner, through increased cyclooxygenase-2 (COX-2) expression, which occurs independently from viral or cellular protein synthesis. RSV infection induces arachidonic acid release through induction of cytoplasmic phospholipase A2 (cPLA2) enzymatic activity and its membrane translocation. Specific inhibitors of cPLA2 significantly block RSV-induced PGE2 secretion, indicating a key role of cPLA2 in viral-induced PG production. Blocking PG secretion, through cPLA2 or COX-2 inhibition, results in impairment of RSV replication and subsequent RSV-mediated epithelial cell responses, suggesting that inhibition of PG secretion could be beneficial in RSV infection by reducing proinflammatory mediator production.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153673     DOI: 10.1016/j.virol.2005.08.012

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Production of prostaglandin E₂ in response to infection with modified vaccinia Ankara virus.

Authors:  Justin J Pollara; April H Spesock; David J Pickup; Scott M Laster; Ian T D Petty
Journal:  Virology       Date:  2012-04-23       Impact factor: 3.616

2.  The role of cyclooxygenase-2 in mechanical ventilation-induced lung injury.

Authors:  Joshua A Robertson; David Sauer; Jeffrey A Gold; Stephanie A Nonas
Journal:  Am J Respir Cell Mol Biol       Date:  2012-05-03       Impact factor: 6.914

3.  Pulmonary cyclooxygenase-1 (COX-1) and COX-2 cellular expression and distribution after respiratory syncytial virus and parainfluenza virus infection.

Authors:  Zaher A Radi; David K Meyerholz; Mark R Ackermann
Journal:  Viral Immunol       Date:  2010-02       Impact factor: 2.257

4.  Alteration in the activation state of new inflammation-associated targets by phospholipase A2-activating protein (PLAA).

Authors:  Fan Zhang; Jian Sha; Thomas G Wood; Cristi L Galindo; Harold R Garner; Mark F Burkart; Giovanni Suarez; Johanna C Sierra; Stacy L Agar; Johnny W Peterson; Ashok K Chopra
Journal:  Cell Signal       Date:  2008-01-17       Impact factor: 4.315

5.  Inhibition of respiratory syncytial virus infections with morpholino oligomers in cell cultures and in mice.

Authors:  Shen-Hao Lai; David A Stein; Antonieta Guerrero-Plata; Sui-Ling Liao; Teodora Ivanciuc; Chao Hong; Patrick L Iversen; Antonella Casola; Roberto P Garofalo
Journal:  Mol Ther       Date:  2008-04-29       Impact factor: 11.454

Review 6.  The host response and molecular pathogenesis associated with respiratory syncytial virus infection.

Authors:  Christine M Oshansky; Wenliang Zhang; Elizabeth Moore; Ralph A Tripp
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

7.  Prostaglandin E2 production during neonatal respiratory infection with mouse adenovirus type 1.

Authors:  Megan C Procario; Mary K McCarthy; Rachael E Levine; Caitlyn T Molloy; Jason B Weinberg
Journal:  Virus Res       Date:  2016-01-18       Impact factor: 3.303

8.  Respiratory syncytial virus induces β2-adrenergic receptor dysfunction in human airway smooth muscle cells.

Authors:  Terri J Harford; Fariba Rezaee; Manveen K Gupta; Vladimir Bokun; Sathyamangla V Naga Prasad; Giovanni Piedimonte
Journal:  Sci Signal       Date:  2021-06-01       Impact factor: 8.192

9.  Ex vivo effect of varespladib on secretory phospholipase A2 alveolar activity in infants with ARDS.

Authors:  Daniele De Luca; Angelo Minucci; Marco Piastra; Paola E Cogo; Francesca Vendittelli; Laura Marzano; Leonarda Gentile; Bruno Giardina; Giorgio Conti; Ettore D Capoluongo
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

10.  Aqueous extract of the edible Gracilaria tenuistipitata inhibits hepatitis C viral replication via cyclooxygenase-2 suppression and reduces virus-induced inflammation.

Authors:  Kuan-Jen Chen; Chin-Kai Tseng; Fang-Rong Chang; Jin-Iong Yang; Chi-Chen Yeh; Wei-Chun Chen; Shou-Fang Wu; Hsueh-Wei Chang; Jin-Ching Lee
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.